secwatch.observer — SEC 8-K summary
======================================

Issuer:     Indivior Pharmaceuticals, Inc. (INDV)
CIK:        0001625297
Form:       8-K
Filed at:   2026-05-04T23:59:59+00:00
Accession:  0001625297-26-000021
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Indivior launches $175M accelerated share repurchase with Barclays
------------------------------------------------------------------

- Initial prepayment of $175M; received 3,717,473 shares from Barclays.
- Final share count based on VWAP during term; settlement by June 22, 2026.
- Part of existing $400M buyback program; $100M remains for future repurchases.
- Company reaffirms prior financial guidance; ASR reflects confidence in strategy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1625297/000162529726000021/0001625297-26-000021-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1625297/000162529726000021/indv-20260504.htm
  HTML page:      https://secwatch.observer/filing/0001625297-26-000021

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer